| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/30/2001 | CA2368364A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 08/29/2001 | EP1127578A1 Remedies for bone metabolic errors |
| 08/29/2001 | EP1127570A2 Production process for polymeric micelle composition charged therein with drug |
| 08/29/2001 | EP1127567A2 Aqueous dispersions of water insoluble organic sunscreens |
| 08/29/2001 | EP1127355A1 Products and methods for brachytherapy |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127115A1 Antisense oligomer |
| 08/29/2001 | EP1127074A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 08/29/2001 | EP1126891A1 Method of depositing a dry powder and dispensing device |
| 08/29/2001 | EP1126884A2 Radiodense compositions |
| 08/29/2001 | EP1126882A2 Stable preparations with hyperforin |
| 08/29/2001 | EP1126881A1 Muco-adhesive polymers, use thereof and method for producing the same |
| 08/29/2001 | EP1126875A2 Pharmaceutically active composition and dispensing device |
| 08/29/2001 | EP1126853A1 Controlled delivery of antidepressants |
| 08/29/2001 | EP1126851A1 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules |
| 08/29/2001 | EP1126848A1 Plastics container containing stabilised drug formulations |
| 08/29/2001 | EP1126846A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1126830A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 08/29/2001 | EP1126829A1 Particles coated with granulated crystalline ibuprofen |
| 08/29/2001 | EP1126828A1 Oral administration of adenosine analogs |
| 08/29/2001 | EP1126827A2 Controlled delivery of active agents |
| 08/29/2001 | EP1126826A1 Multiparticulate modified release composition |
| 08/29/2001 | EP1126825A1 Use of xanthan gums for preparing pharmaceutical compositions |
| 08/29/2001 | EP1126824A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 08/29/2001 | EP1126823A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 08/29/2001 | EP1126822A1 Controlled release liquid delivery compositions with low initial drug burst |
| 08/29/2001 | EP1126821A1 Improved fast disintegrating tablet |
| 08/29/2001 | EP1126820A1 Controlled release drug delivery |
| 08/29/2001 | EP1126785A1 Manganese compositions and methods for mri |
| 08/29/2001 | EP1021241B1 Method for producing a powder product from a liquid substance or mixture of substances |
| 08/29/2001 | EP0988106B1 Method for producing small-particle preparations of biologically active substances |
| 08/29/2001 | EP0963198A4 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN |
| 08/29/2001 | EP0914043A4 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 08/29/2001 | EP0892636B1 Ophthalmic solutions viscosified with tamarind seed polysaccharide |
| 08/29/2001 | EP0876141B1 Preparations of non-steroidal analgesics |
| 08/29/2001 | EP0835097B1 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories |
| 08/29/2001 | EP0831782A4 Methods and system for processing dispersible fine powders |
| 08/29/2001 | EP0828523B1 Transdermal therapeutic system identified without printing inks and process for manufacturing the same |
| 08/29/2001 | EP0828480B1 Novel pharmaceutical pellet formulation |
| 08/29/2001 | EP0810868B1 Use of piperine as a gastrointestinal absorption enhancer |
| 08/29/2001 | EP0810857B1 Colonic drug delivery composition |
| 08/29/2001 | EP0775111B1 Stable vitamin a |
| 08/29/2001 | EP0768868B1 Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation |
| 08/29/2001 | EP0756480B1 Sustained-release matrix pellets and method for preparing them |
| 08/29/2001 | EP0711175B1 Topical compositions for re-epitheliazation of persistent epithelial defects |
| 08/29/2001 | EP0606486B1 Pharmaceutical preparation for intra-airway administration |
| 08/29/2001 | CN2444601Y Porosity slow releasing medicinal plaster |
| 08/29/2001 | CN1310725A Carrangeenan compositions, and processes for their production |
| 08/29/2001 | CN1310640A Microparticles produced from cyclic olefin copolymers and their use for the controlled release of active agents |
| 08/29/2001 | CN1310630A Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 08/29/2001 | CN1310623A Bioimplant formulation |
| 08/29/2001 | CN1310617A Therapeutic system with addition of nacreous pigments |
| 08/29/2001 | CN1310616A Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 08/29/2001 | CN1310615A Estradiol-containing patch for transdermal administration of hormones |
| 08/29/2001 | CN1310614A Estradiol-containing patch for transdermal administration of hormones |
| 08/29/2001 | CN1310613A Rapidly disintegrable solid preparation |
| 08/29/2001 | CN1310612A Novel particulate formulations |
| 08/29/2001 | CN1310611A Pressurized metered dose inhalers and pharmaceutical aerosol formulations |
| 08/29/2001 | CN1310610A Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 08/29/2001 | CN1310195A Aqueous dispersion body of water insoluble organic ultraviolet ray filtering material |
| 08/29/2001 | CN1310025A Therapeutical compound and its application |
| 08/29/2001 | CN1310019A Maizhenhua extract as coronary heart disease treating medicine and its preparation |
| 08/29/2001 | CN1310016A Acid resistant enteric coated capsule of active binding bifidobacterium strain and its preparation |
| 08/29/2001 | CN1310005A External-use Chinese medicine plaster |
| 08/29/2001 | CN1309996A Deer fetus oral liquid and its preparation |
| 08/29/2001 | CN1309979A Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes |
| 08/29/2001 | CN1309972A Garter snake capsule |
| 08/29/2001 | CN1309966A Rifapentine or Rifampicin microemulsion and suspension perfusate and injection and their preparation |
| 08/29/2001 | CN1309958A Preparation process and equipment for Chinese medicine tablet for treating coronary heart disease |
| 08/29/2001 | CN1309940A Compound structure of adhesive stroma contaning one or several active agent |
| 08/29/2001 | CN1309920A Sea-buckthorn seed kernel powder producing process |
| 08/29/2001 | CN1070077C Medicine for treating diabets and its preparing process |
| 08/29/2001 | CN1070072C Enterelcosis capsule |
| 08/29/2001 | CN1070064C Method for preparing ointment for curing burns and scalds |
| 08/29/2001 | CN1070058C Medicine for treating inflammatory piles |
| 08/29/2001 | CN1070055C Deerhorn glue oral liquid |
| 08/29/2001 | CN1070053C Method for preparing butethanol using for injection |
| 08/29/2001 | CN1070052C Application of bicycloheptane derivative |
| 08/29/2001 | CN1070051C Substrate for medical plaster |
| 08/29/2001 | CN1070050C Medicinal plaster for external use |
| 08/29/2001 | CA2337661A1 Stabilized granulocyte colony stimulating factor |
| 08/28/2001 | US6281371 Lipopolyamines, and the preparation and use thereof |
| 08/28/2001 | US6281341 Hetero-polysaccharide conjugate and methods of making and using the same |
| 08/28/2001 | US6281282 Adjustment ph; salt formation |
| 08/28/2001 | US6281256 Leaching particles by gas foaming |
| 08/28/2001 | US6281246 Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments |
| 08/28/2001 | US6281241 Use of melatonin for the treatment of androgenetic alopecia |
| 08/28/2001 | US6281239 Tissue softening composition containing urea and an antifungal composition |
| 08/28/2001 | US6281236 Containing allantoin and an emulsifier has improved stability coming from the adjustment of the ph to a range of 4.5 to 5.8. |
| 08/28/2001 | US6281224 Benzalkonium chloride effective as a preservative, and tromethamine effective to keep the solution stable and clear and lowers eye irritation |
| 08/28/2001 | US6281208 E.g., 3,4-dihydro-2-(5-methoxy-2-(3-(n-methyl-n-(2-((3,4-methylenedi oxy) phenoxy)ethyl)amino)propoxy)phenyl)-4-methyl-3-oxo-2h-1,4-benz |
| 08/28/2001 | US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/28/2001 | US6281203 Cosmetic and/or dermatological composition containing salicyclic acid derivative and its use |
| 08/28/2001 | US6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancers |
| 08/28/2001 | US6281192 Derived from mammalian milk or milk byproducts. |
| 08/28/2001 | US6281175 Medical emulsion for lubrication and delivery of drugs |
| 08/28/2001 | US6281015 Introducing a microsphere with a bioactive factor to a hepatocyte seeded biodegradable polymer matrix into a transplantation site; enhancing survival and proliferation of transplanted cells |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/28/2001 | US6280773 Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative |